AC Immune SA
NASDAQ:ACIU
AC Immune SA
NASDAQ:ACIU
Price:
4.65 USD
17.13%
Market Closed
Updated:
Jun 1, 2024
AC Immune SA
Net Income
|
AC Immune SA
Net Income Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AC Immune SA
NASDAQ:ACIU
|
Net Income
-CHf54.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Net Income
-$240.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Net Income
-$217.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Net Income
CHf10.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Idorsia Ltd
SIX:IDIA
|
Net Income
-CHf297.9m
|
CAGR 3-Years
13%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Net Income
-CHf13.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
See Also
What is AC Immune SA's Net Income?
Net Income
-54.2m
CHF
-54.2m
CHF
Based on the financial report for Dec 31, 2023, AC Immune SA's Net Income amounts to -54.2m CHF.
What is AC Immune SA's Net Income growth rate?
Net Income CAGR 5Y
-1%
-1%
Over the last year, the Net Income growth was 23%. The average annual Net Income growth rates for AC Immune SA have been 4% over the past three years , -1% over the past five years .
You don't have any saved screeners yet
